Market capitalization | CAD1.16b |
Enterprise Value | CAD1.62b |
PER (TTM) P/E ratio | 38.83 |
EV/FCF (TTM) EV/FCF | 35.72 |
EV/Sales (TTM) EV/Sales | 1.93 |
P/S ratio (TTM) P/S ratio | 1.38 |
P/B ratio (TTM) P/B ratio | 1.43 |
Sales growth (TTM) Sales growth | 36.95% |
Turnover (TTM) Turnover | CAD838.19m |
As a free StocksGuide basic user, you can view the scores for all 6,953 shares worldwide.
15 Analysts have issued a WELL Health Technologies forecast:
15 Analysts have issued a WELL Health Technologies forecast:
Dec '23 |
+/-
%
|
||
Turnover | 776 776 |
36%
36%
|
|
Gross income | 312 312 |
26%
26%
|
|
EBITDA | 102 102 |
25%
25%
|
EBIT (operating result) EBIT | 41 41 |
55%
55%
|
Net profit | 0.08 0.08 |
94%
94%
|
Figures in millions CAD.
If you wish, you can receive an e-mail every morning in time for breakfast containing all the stock news relevant to you.
WELL Health Technologies Corp. owns and operates a portfolio of primary healthcare facilities. It operates through Clinical, and Electronic Medical Records (EMR) segments. The Clinical segment operates a network of clinics across Canada. The EMR segment provides Open Source Clinical Application Resource (OSCAR) EMR software and services to clinics. The company was founded by Hamed Shahbazi on November 23, 2010 and is headquartered in Vancouver, Canada.
Head office | Canada |
CEO | Hamed Shahbazi |
Founded | 2010 |
Website | www.well.company |
StocksGuide is the tool for easily finding, analyzing and monitoring shares. Learn from successful investors and make well-founded investment decisions. We make you a self-determined investor.